Selbyville, Delaware, June 03, 2021 (GLOBE NEWSWIRE) -- According to credible sources, global injectable drugs market was appraised at USD 414.88 billion in the year 2020 and is anticipated to expand considerably over 2021-2026.
The study also emphasizes on vital aspects of various industry segmentations, including molecule type, delivery method, and product terrain, along with regional divisions. An in-depth scrutiny of each segment, concerning their respective revenue contributions, market shares, and estimated compound annual growth rates is also incorporated.
In addition to this, the research article documents the competitive developments and key trends prevailing in this business sphere. It further summarizes the key players and underlines the business-centric strategies to ensure high profitability and improved decision making among stakeholders and industrialists.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3855666/
Increasing incidence of auto-immune disorders such as rheumatoid arthritis and multiple sclerosis, along with pervasiveness of chronic diseases like diseases like diabetes and cancer, and growing geriatric populace are the factors driving the growth of global injectable drugs market. Additionally, rising use of self-administered injectable formulations like pen injectors, auto injectors, needle free injectors and prefilled syringes is bolstering the demand for injectable drugs.
However, high pricing of the drugs, stricter regulations, issues of patent expiry, and shortages of medications are the factors restraining the industry growth.
Market segmentation overview
Based on product ambit, global injectable drugs market is segmented into complex biologics, vaccines, conventional therapeutics, and insulin among others. Speaking of molecule type, the industry sphere is divided into large molecule and small molecule. Moving on to delivery method, the marketplace is fragmented into prefilled syringes, infusions, and others.
Elaborating regional spectrum
Worldwide injectable drugs market sphere, based on geographical analysis, is bifurcated as North America, Asia-Pacific, Europe, and the rest of the world.
Among these, North America currently accounts for the largest share in global injectable drugs industry and is likely to show similar growth patterns in the subsequent years. Advancements in healthcare infrastructure, increasing investments in research & development, rising adoption of oncology related drugs to treat cancers, along with presence of notable players in the region are complementing the business dynamics in North America.
Meanwhile, Asia-Pacific region is predicted to generate notable gains for the market contenders in the ensuing years, on account of increasing number of innovative drug formulations.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-injectable-drugs-market-2021-edition-analysis-by-molecule-small-large-delivery-prefilled-infusion-others-product-by-region-by-country-market-insights-and-forecast-with-impact-of-covid-19-2021-2026
Global Injectable Drugs Market by Product (Revenue, USD Billion, 2016-2026)
- Complex Biologics
- Vaccines
- Conventional Therapeutics
- Insulin
Global Injectable Drugs Market by Molecule (Revenue, USD Billion, 2016-2026)
- Large Molecule
- Small Molecule
Global Injectable Drugs Market by Delivery (Revenue, USD Billion, 2016-2026)
- Pre-Filled Syringes
- Infusions
- Others
Global Injectable Drugs Market by Regional Terrain (Revenue, USD Billion, 2016-2026)
North America
- U.S.
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
Europe
- UK
- France
- Germany
- Italy
Rest of the World
Global Injectable Drugs Market Competitive Outlook (Revenue, USD Billion, 2016-2026)
- Baxter International Inc.
- Novo Nordisk A/S
- The Merck Group
- Sanofi S.A.
- AstraZeneca plc
- Eli Lilly and Company
- Novartis International AG
- GlaxoSmithKline plc
- Pfizer Inc.
- Johnson & Johnson
Table of Content:
1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Injectable Drugs Market: Product Outlook
4. Global Injectable Drugs Market: Sizing and Forecast
4.1 Global Injectable Drugs Market Size, By Value, Year 2016-2026
5. Global Injectable Drugs Market Segmentation - By Product, By Molecule, By Delivery
5.1 Competitive Scenario of Global Injectable Drugs Market: By Product
5.1.1 Complex Biologics ?? Market Size and Forecast (2016-2026)
5.1.2 Conventional Therapeutics ?? Market Size and Forecast (2016-2026)
5.1.3 Vaccines ?? Market Size and Forecast (2016-2026)
5.1.4 Insulin ?? Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Injectable Drugs Market: By Molecule
5.2.1 Small Molecule ?? Market Size and Forecast (2016-2026)
5.2.2 Large Molecule ?? Market Size and Forecast (2016-2026)
5.3 Competitive Scenario of Global Injectable Drugs Market: By Delivery
5.3.1 Pre-filled Syringe ?? Market Size and Forecast (2016-2026)
5.3.2 Infusions - Market Size and Forecast (2016-2026)
5.3.3 Others?? Market Size and Forecast (2016-2026)
6. Global Injectable Drugs Market: Regional Analysis
6.1 Competitive Scenario of Global Injectable Drugs Market: By Region
7. North America Injectable Drugs Market: An Analysis (2016-2026)
7.1 North America Injectable Drugs Market: Size and Forecast (2016-2026), By Value
7.2 North America Injectable Drugs Market ?? Prominent Companies
7.3 Market Segmentation By Product (Complex Biologics, Conventional Therapeutics, Vaccines and Insulin)
7.4 Market Segmentation By Molecule (Small Molecule and Large Molecule)
7.5 Market Segmentation By Delivery (Pre-filled Syringe, Infusions and Others)
8. Europe Injectable Drugs Market: An Analysis (2016-2026)
8.1 Europe Injectable Drugs Market: Size and Forecast (2016-2026), By Value
8.2 Europe Injectable Drugs Market - Prominent Companies
8.3 Market Segmentation By Product (Complex Biologics, Conventional Therapeutics, Vacccines, Insulin)
8.4 Market Segmentation By Molecule (Small Molecule and Large Molecule)
8.5 Market Segmentation By Delivery (Prefilled Syringe, Infusions and Others)
9. Asia Pacific Injectable Drugs Market: An Analysis (2016-2026)
9.1 Asia Pacific Injectable Drugs Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Injectable Drugs Market - Prominent Companies
9.3 Market Segmentation By Product (Complex Biologics, Conventional Therapeutics, Vacccines, Insulin)
9.4 Market Segmentation By Molecule (Small Molecule and Large Molecule)
9.5 Market Segmentation By Delivery (Prefilled Syringe, Infusions, Others)
10. Global Injectable Drugs Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11.Market Attractiveness
11.1 Market Attractiveness Chart of Global Injectable Drugs Market - By Product, 2026
11.2 Market Attractiveness Chart of Global Injectable Drugs Market - By Molecule, 2026
11.3 Market Attractiveness Chart of Global Injectable Drugs Market - By Delivery, 2026
11.4 Market Attractiveness Chart of Global Injectable Drugs Market - By Region, 2026
12.Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis
13. Regulatory Compliance
14. Company Analysis
Related Report:
Antiviral Drugs Market Size, Industry Analysis Report, Regional Outlook, Type Potential, Price Trends, Competitive Market Share & Forecast, 2021 - 2027
The anti-viral drugs market is likely to witness exponential growth over the forecast time period owing to large patient pool suffering from COVID-19 infection, increasing prevalence of sexually transmitted diseases, and instances of seasonal flu across the U.S. Antiviral drugs are usually prescription medicines that efficiently fight against viruses in the body. These come in inhaled powder form, liquid form, and pills form. When utilized as directed, these drugs aid in reducing the duration of flu symptoms in otherwise healthy children as well as adults and might also reduce the danger of common flu symptoms.
Increasing CVOVID-19 cases across the world is further driving the demand for anti-viral drugs. As per mortality surveillance data of NCHS on 25th February 2021, nearly 19.3 per cent of the deaths that happened in the week ending 20th February 2021 were mainly because of COVID-19, influenza, and pneumonia. In fact, Remdesivir is the only anti-viral drug approved by the FDA for the treatment of SARS-CoV-2 virus or COVID-19.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.